Chief Executive Officer
Prior to joining IOTA NanoSolutions Limited, Andrew was the Global Business Director at Oxonica PLC, a world leading Nanotechnology Company. He has previously held senior positions at Ernst and Young LLP in London, and in international business management within the Specialty Chemicals sector, in both the UK and Switzerland. Andrew began his career with ICI, and over a period of 18 years gained significant experience of the chemicals sector, holding senior roles in the International Sales, Business Unit Management, Marketing and Purchasing. Andrew has an MBA from the University of Birmingham Business School and a BSc (Hons) degree in Biology from the University of Nottingham. He also has a Graduate Diploma in Marketing (MCIM) from Manchester Business School/Chartered Institute of Marketing.
Pharmaceutical Programme Director & Cofounder
Alison was involved in the original Unilever/Liverpool collaboration that led to the formation of IOTA NanoSolutions Limited, developing the technology for use within the Unilever HPC Business. Prior to working on the IOTA NanoSolutions technology, Alison worked on numerous projects within Unilever as part of the Physical Sciences Group which included polymer chemistry, synthetic organic chemistry, HTE, sensory molecules and colloid chemistry. Before joining Unilever in 1998, Alison gained post doctoral medicinal chemistry experience at the University of Manchester, School of Pharmacy and Pharmaceutical Sciences, developing new anti-cancer drugs. She gained her BSc in Chemistry (1994) and Ph.D. (1997) from the University of Birmingham in the area of fluorinated dyes as part of a joint collaboration with Courtaulds. Alison has also held positions at Rhodia, working on phosphorus flame-retardants, and at the University of Birmingham working on chiral ligands. She is co-author on 5 papers and 20 published patents.
Business Development Director
Christopher joined IOTA NanoSolutions Limited in March 2009 as Business Development Director and he is responsible for business development in the pharmaceutical sector. Immediately prior to joining IOTA NanoSolutions Christopher held the position of Pharmaceutical Business Unit Manager at IMCD UK Limited (the former bp Chemical subsidiary Honeywill & Stein Limited), a leading global distributor of specialty chemicals and functional ingredients. He also held other senior positions within IMCD including European Marketing Manager, European Product Manager, and General Manager of IMCD’s branch office in India. Christopher began his career within the Pharmaceuticals and Fine Chemicals division at Univar Limited, and over a period of more than 10 years has gained significant experience in the pharmaceutical, biotechnology and specialty chemical sectors, having held senior roles in international sales, marketing and purchasing. Christopher has a BSc (Hons) degree in Biological Sciences from the University of Sussex.